Schedule

Print
Monday, May 04, 2020
7:00am to 8:00am Registration and Continental Breakfast
8:00am to 8:15am Welcome and Introduction

A. Enrique Caballero, MD, Melinda D. Maryniuk, MEd, RDN, CDE, FADA and J. Kevin Tucker, MD

8:15am to 8:45am Diabetes Report Card: How Are We Doing in Helping Our Patients?

A. Enrique Caballero, MD

Are Genes or Lifestyle Factors More Important in My Patient with Type 2 Diabetes?

8:45am to 9:25am Genetic Factors in the Development and Course of Type 2 Diabetes

Jose C. Florez, MD, PhD

9:25am to 10:05am Lifestyle Factors in the Development and Course of Type 2 Diabetes

Osama Hamdy, MD, PhD

10:05am to 10:20am Break

Refreshments provided

10:20am to 10:45am Panel Discussion and Q & A

Are the Pathophysiological Defects and Their Treatment Implications the Same in My Patients with Type 2 Diabetes across Various Age Groups?

10:45am to 11:25am Type 2 Diabetes in Children and Adolescents

Joseph Wolfsdorf, MB, BCh

11:25am to 12:05pm Type 2 Diabetes in the Elderly

Medha Munshi, MD

12:05pm to 12:30pm Panel Discussion and Q & A
12:30pm to 1:40pm Lunch*

Should I Focus on the Quantity or Quality of Food in My Patient with Type 2 Diabetes?

1:40pm to 2:10pm Nutrition Recommendations and Guidelines

Melinda D. Maryniuk, MEd, RDN, CDE, FADA

2:10pm to 2:45pm The Quantity of Food Matters: The Importance of Caloric Intake

Susan B. Roberts, PhD

2:45pm to 3:20pm The Quality of Food Intake: The Current Evidence

Dariush Mozaffarian, MD, MPH, DrPH

3:20pm to 3:35pm Break

Refreshments provided

3:35pm to 4:00pm Panel Discussion and Q & A
4:00pm to 4:45pm Educating the Patient with Diabetes on Self-Care Behaviors

Melinda D. Maryniuk, MEd, RDN, CDE, FADA

Tuesday, May 05, 2020
7:00am to 8:00am Continental Breakfast

Should I Emphasize Aerobic or Strength Exercise in My Patients with Diabetes?

8:00am to 8:35am The Impact of Exercise on Glucose Homeostasis

Roeland Middelbeek, MD, MSc

8:35am to 9:10am Practical Exercise Recommendations for the Patient with Diabetes
9:10am to 9:30am Panel Discussion and Q & A

How Do Race, Social and Cultural Factors Influence My Patient with Diabetes?

9:30am to 9:45am Cross-Cultural Communication: An Introductory Note

A. Enrique Caballero, MD

9:45am to 10:15am Diabetes in Latino/Hispanic Americans

A. Enrique Caballero, MD

10:15am to 10:30am Break

Refreshments provided

10:30am to 11:00am Diabetes in African Americans

Michele David, MD, MBA, MPH, FACP

11:00am to 11:30am Diabetes in Asian Americans

Ka Hei Karen Lau, MS, RD, LDN, CDE

11:30am to 12:00pm Diabetes in Arab Americans

Joanna Mitri, MD, MS

12:00pm to 12:25pm Panel Discussion and Q & A
12:25pm to 1:30pm Lunch*

How Should I Manage Dyslipidemia and Hypertension in My Patient with Diabetes?

1:30pm to 2:15pm Statins or Something Else in the Management of Dyslipidemia?

Om P. Ganda, MD

2:15pm to 3:00pm ACE Inhibitors/ARBs or Something Else for the Management of Hypertension?

Robert C. Stanton, MD

3:00pm to 3:30pm Panel Discussion and Q & A
3:30pm to 3:45pm Break

Refreshments provided

3:45pm to 4:45pm Keynote Lecture: Lifestyle Modification or Bariatric Surgery for the Patient with Obesity and Diabetes?

Caroline M. Apovian, MD

Wednesday, May 06, 2020
7:00am to 8:00am Continental Breakfast

What New Technologies Should I Recommend to My Patient with Diabetes?

8:00am to 8:45am An Update on Continuous Glucose Monitoring

Devin Steenkamp, MD

8:45am to 9:30am Insulin Pumps: Why, When, Which, How and for Whom?

Geralyn R. Spollett, MSN, ANP-BC, CDE

9:30am to 10:15am The Bionic Pancreas: Is It Ready for Prime Time?

Steven J. Russell MD, PhD

10:15am to 10:30am Break

Refreshments provided

10:30am to 11:00am Panel Discussion and Q & A

Can I Truly Prevent Type 2 Diabetes in the Patients I See in My Practice?

11:00am to 11:50am An Update on Diabetes Prevention Strategies

A. Enrique Caballero, MD

11:50am to 1:00pm Lunch*

What Anti-Diabetes Medications Should I Select to Improve Glycemic Control and Reduce the Risk of Complications in My Patients?

1:00pm to 1:15pm Clinical Case Presentation: Setting the Stage

A. Enrique Caballero, MD

1:15pm to 1:50pm Insulin Therapy

Marie E. McDonnell, MD

1:50pm to 2:25pm Metformin, SFU, TZDs and AGI: An update

Deborah J. Wexler, MD, MSc 

2:25pm to 3:00pm Incretin-Based Therapies
3:00pm to 3:15pm Break

Refreshments provided

3:15pm to 3:50pm SGLT-2 Inhibitors

Silvio E. Inzucchi, MD

3:50pm to 4:30pm Panel Discussion and Q & A
4:30pm to 4:45pm Closing Remarks

A. Enrique Caballero, MD, Melinda D. Maryniuk, MEd, RDN, CDE, FADA and J. Kevin Tucker, MD

*Lunch on your own.